Hello,
October 2022, I was diagnosed with Gleason 3+4 prostate cancer. I had the multiparametric MRI and fusion biopsy. Two months later I had the F18 PSMA PET/CT scan, confirming it was confined to the prostate and not yet metastisized. PSA had risen from about 5.2, up to 13.4 over the course of a year.
I had HDR Brachytherapy Mar. 7, 2023. It was two sessions over two consecutive days.
I had my first PSA test, 3 months after the procedure and was expecting it to be low. The test was 4.6 and I'm very worried that the Brachytherapy did not work as intended.
Have any of you had similar outcomes and if so, what was done about it?
Paul